Cholestatic hepatitis is a form of liver inflammation where bile flow is blocked or severely reduced, causing bile components to build up inside the liver and damage its cells. Unlike other types of hepatitis that primarily injure liver cells through infection or toxins, cholestatic hepatitis involves a combination of impaired bile drainage and the resulting inflammation. The backup of bile acids and other biliary chemicals directly harms liver tissue while also triggering an immune response that compounds the damage.
How Bile Backup Damages the Liver
Your liver continuously produces bile, a fluid essential for digesting fats and eliminating waste products. Bile normally flows through a network of tiny ducts inside the liver, merging into larger ducts that carry it to the gallbladder and small intestine. In cholestatic hepatitis, something disrupts this flow. When bile can’t move forward, its components, particularly bile acids, accumulate beyond the limits of the liver’s normal architecture.
This accumulation sets off a chain of injury. Bile acids are corrosive at high concentrations: they damage the membranes of bile duct cells, break apart the tight junctions between cells, and directly injure liver tissue. The damaged duct cells then release signaling molecules that recruit immune cells, including T cells, macrophages, and natural killer cells. What starts as a drainage problem quickly becomes an inflammatory one, with the immune response adding a second layer of tissue destruction.
Intrahepatic vs. Extrahepatic Causes
The causes of cholestatic hepatitis split into two broad categories based on where the bile flow problem originates.
Intrahepatic Causes
These involve problems inside the liver itself. Viral hepatitis, acute alcohol-related hepatitis, and certain genetic conditions affecting bile transporters can all impair bile formation or secretion at the cellular level. Cholestasis of pregnancy is another well-known intrahepatic cause, typically arising in the third trimester. Bacterial infections and sepsis can also disrupt bile flow from within the liver. Some autoimmune conditions, including primary biliary cholangitis and primary sclerosing cholangitis, cause ongoing damage to the small bile ducts inside the liver, leading to chronic cholestasis.
Extrahepatic Causes
These involve a physical blockage in the bile ducts outside the liver. Gallstones lodged in the common bile duct are one of the most frequent culprits. Tumors of the bile duct, pancreas, or the area where the bile duct meets the small intestine can also obstruct flow. Bile duct strictures, whether from prior surgery, inflammation, or sclerosing cholangitis, create narrowing that traps bile upstream.
Medications as a Common Trigger
Drug-induced cholestatic hepatitis deserves special attention because it accounts for a significant share of cases and can catch people off guard. Antibiotics are among the most frequent offenders. Amoxicillin-clavulanate (the combination antibiotic commonly prescribed for sinus and ear infections) is a well-known cause, as are penicillins and cephalosporins. Jaundice from these drugs can appear days or even several weeks after the antibiotic course ends, which makes it easy to miss the connection.
Other implicated medications include rifampin (used for tuberculosis), sulfonylureas (used for diabetes), methimazole (used for overactive thyroid), and oral contraceptives. Historically, the antipsychotic chlorpromazine was the most common cause of drug-induced liver disease with jaundice in the United States, though cases are now rare because the drug class has largely fallen out of use.
Symptoms and the Problem of Cholestatic Itch
The hallmark symptom is jaundice: yellowing of the skin and eyes caused by bilirubin backing up into the bloodstream. Urine often turns dark, and stools may become pale or clay-colored because less bile pigment reaches the intestine. Nausea, fatigue, and upper abdominal discomfort are common. In acute cases, liver enzymes in the blood rise sharply, sometimes before jaundice even appears.
Perhaps the most distressing symptom is intense itching. Between 80% and 100% of people with cholestatic liver disease experience pruritus, and many describe it as debilitating and unrelenting. Unlike the itch from hives or allergic reactions, cholestatic itch is not driven by histamine, which is why standard antihistamines rarely help. Instead, the itching appears to involve multiple substances that build up during cholestasis: bile acids activate itch receptors on sensory nerve fibers, an enzyme called autotaxin produces a fat-signaling molecule that contributes to the sensation, and even bilirubin itself can bind to specific itch receptors. There is no primary rash, but people often develop scratch marks and secondary skin lesions from trying to get relief.
How It Is Diagnosed
Blood tests are the starting point. A cholestatic pattern shows elevated levels of alkaline phosphatase (ALP) and GGT, two enzymes that rise when bile ducts are damaged or obstructed. Standard liver enzymes (aminotransferases) may also be elevated, reflecting direct injury to liver cells from bile acid toxicity, but the ALP and GGT elevations are disproportionately high compared to a purely inflammatory hepatitis. Bilirubin levels are typically raised as well, correlating with the degree of jaundice.
Once blood work suggests cholestasis, the next step is usually imaging to determine whether the blockage is inside or outside the liver. Ultrasound is often the first test, looking for dilated bile ducts or gallstones. If more detail is needed, magnetic resonance cholangiopancreatography (MRCP) provides a noninvasive, detailed view of the entire biliary system. MRCP is particularly useful for identifying strictures, tumors, and blockages at multiple levels. It can often replace the more invasive alternative, endoscopic retrograde cholangiopancreatography (ERCP), which involves threading a scope through the mouth into the small intestine. ERCP is generally reserved for situations where a therapeutic intervention, like removing a stone or placing a stent, is needed at the same time. Liver biopsy may be considered when the cause remains unclear after blood work and imaging, particularly to distinguish between drug reactions, autoimmune conditions, and other intrahepatic causes.
Treatment Depends on the Cause
The most effective treatment targets whatever is blocking or impairing bile flow. For extrahepatic obstruction, that often means removing gallstones or placing a stent to open a narrowed duct. For drug-induced cholestatic hepatitis, the key step is stopping the responsible medication. Most drug-induced cases resolve over weeks to months after the offending drug is discontinued, though jaundice can linger longer than patients expect.
For chronic cholestatic conditions like primary biliary cholangitis, ursodeoxycholic acid (often called UDCA or “urso”) is the first-line treatment. It’s a naturally occurring bile acid that can improve bile flow and has been shown to improve transplant-free survival regardless of disease stage. For people who don’t respond adequately to UDCA, newer options have recently emerged. In 2024, two medications (elafibranor and seladelpar) received accelerated FDA approval as second-line therapies for primary biliary cholangitis. An older second-line option, obeticholic acid, had its full approval declined by the FDA in late 2024 due to concerns about its overall benefit-risk profile, including its tendency to worsen itching.
Managing cholestatic itch itself is a separate challenge. Because the itch isn’t histamine-driven, it requires different approaches. Some of the newer therapies for cholestatic liver disease also reduce itching. In clinical trials, bezafibrate achieved at least a 50% reduction in itch intensity for 45% of patients compared to placebo. For people with refractory itching that doesn’t respond to standard treatments, the symptom can be significantly challenging to control and may require specialized care.
Complications of Prolonged Cholestasis
When cholestasis persists, the consequences extend beyond the liver. Bile is essential for absorbing dietary fat, so chronic bile deficiency leads to fat malabsorption. This in turn impairs absorption of fat-soluble vitamins: A, D, E, and K. Vitamin D deficiency can weaken bones over time. Vitamin K deficiency increases bleeding risk because the body needs it to make clotting factors. Vitamin A deficiency can affect vision, and vitamin E deficiency can cause neurological problems. Detecting these deficiencies can be tricky because standard blood tests for vitamin levels may not be accurate in the setting of cholestatic liver disease.
If the underlying cause isn’t treated, ongoing bile accumulation and inflammation can lead to fibrosis (scarring) of the liver, eventually progressing to cirrhosis. At that stage, the liver loses its ability to function normally, and transplantation may become the only option.